Semin Thromb Hemost 2015; 41(01): 099-107
DOI: 10.1055/s-0034-1398385
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hemostasis and Thrombosis in Major Liver Resection

Andrea J. Cross
1   Department of Surgery, Christchurch Hospital, Christchurch, New Zealand
,
Saxon J. Connor
1   Department of Surgery, Christchurch Hospital, Christchurch, New Zealand
› Author Affiliations
Further Information

Publication History

Publication Date:
15 January 2015 (online)

Abstract

The liver plays an important role in the balance between hemostasis and thrombosis. Hepatic resection, particularly when performed in the presence of underlying parenchymal liver disease, can cause perturbation of this balance. This review summarizes the changes that occur in normal hemostasis and thrombosis before, during, and after nontransplant hepatic resection and, wherever possible, provides strategies for the perioperative management of bleeding and thrombosis.

 
  • References

  • 1 Foster JH. Survival after liver resection for cancer. Cancer 1970; 26 (3) 493-502
  • 2 Ekberg H, Tranberg KG, Andersson R , et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986; 73 (9) 727-731
  • 3 Zimmitti G, Roses RE, Andreou A , et al. Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections. J Gastrointest Surg 2013; 17 (1) 57-64 , discussion 64–65
  • 4 Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247 (1) 125-135
  • 5 Siu J, McCall J, Connor S. Systematic review of pathophysiological changes following hepatic resection. HPB (Oxford) 2014; 16 (5) 407-421
  • 6 Esmon CT. The protein C pathway. Chest 2003; 124 (3, Suppl): 26S-32S
  • 7 Esmon CT. Coagulation and inflammation. J Endotoxin Res 2003; 9 (3) 192-198
  • 8 Vasse M. Protein Z, a protein seeking a pathology. Thromb Haemost 2008; 100 (4) 548-556
  • 9 Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb Hemost 2008; 34 (8) 772-778
  • 10 Ferland G, Sadowski JA, O'Brien ME. Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest 1993; 91 (4) 1761-1768
  • 11 Çakır T, Cingi A, Yeğen C. Coagulation dynamics and platelet functions in obstructive jaundiced patients. J Gastroenterol Hepatol 2009; 24 (5) 748-751
  • 12 Ben-Ari Z, Panagou M, Patch D , et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol 1997; 26 (3) 554-559
  • 13 Pihusch R, Rank A, Göhring P, Pihusch M, Hiller E, Beuers U. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol 2002; 37 (5) 548-555
  • 14 Papadopoulos V, Filippou D, Manolis E, Mimidis K. Haemostasis impairment in patients with obstructive jaundice. J Gastrointestin Liver Dis 2007; 16 (2) 177-186
  • 15 Kennedy TJ, Yopp A, Qin Y , et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 2009; 11 (5) 445-451
  • 16 Lisman T, Caldwell SH, Burroughs AK , et al; Coagulation in Liver Disease Study Group. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 2010; 53 (2) 362-371
  • 17 Tripodi A, Salerno F, Chantarangkul V , et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41 (3) 553-558
  • 18 Nuttall GA, Brost BC, Connis RT , et al; American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105 (1) 198-208
  • 19 Lisman T, Leebeek FWG. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 2007; 24 (4) 250-258
  • 20 Mannucci PM. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No. J Thromb Haemost 2006; 4 (4) 721-723
  • 21 Massicotte L, Beaulieu D, Thibeault L , et al. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation 2008; 85 (7) 956-962
  • 22 O'Shaughnessy DF, Atterbury C, Bolton Maggs P , et al; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126 (1) 11-28
  • 23 Massicotte L, Lenis S, Thibeault L, Sassine M-P, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006; 12 (1) 117-123
  • 24 Søgaard KK, Horváth-Puhó E, Grønbaek H, Jepsen P, Vilstrup H, Sørensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009; 104 (1) 96-101
  • 25 Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy?. HPB (Oxford) 2009; 11 (6) 459-464
  • 26 Lee AYY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003; 107 (23) (Suppl. 01) I17-I21
  • 27 Falanga A, Panova-Noeva M, Russo L. Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol 2009; 22 (1) 49-60
  • 28 Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 2013; 11 (2) 223-233
  • 29 Lyman GH, Khorana AA, Falanga A , et al; American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25 (34) 5490-5505
  • 30 Srivastava A, Brewer AK, Mauser-Bunschoten EP , et al; Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Guidelines for the management of hemophilia. Haemophilia 2013; 19 (1) e1-e47
  • 31 Kokudo T, Uldry E, Degrauwe S, Demartines N, Halkic N. A successful case of right hepatectomy in a patient with von Willebrand disease. Haemophilia 2014; 20 (2) e191-e192
  • 32 Buchanan GS, Rodgers GM, Ware Branch D. The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation. Best Pract Res Clin Obstet Gynaecol 2003; 17 (3) 397-411
  • 33 Lille S, Blackstone R. Inherited thrombophilias: are they an important risk factor in bariatric and post-bariatric surgery?. Bariatric Times 2008; ; Available at: http://bariatrictimes.com/inherited-thrombophilias-are-they-an-important-risk-factor-in-bariatric-and-post-bariatric-surgery/ . Accessed January 13, 2015
  • 34 Kujovich JL, Factor V Leiden Thrombophilia. In: Pagon RA, Adam MP, Ardinger HH. , et al. eds. Gene Review, 2010. University of Washington, Seattle (WA). Available online at http://www.ncbi.nlm.nih.gov/books/NBK1368/
  • 35 Huntington JT, Royall NA, Schmidt CR. Minimizing blood loss during hepatectomy: a literature review. J Surg Oncol 2014; 109 (2) 81-88
  • 36 Gurusamy KS, Pamecha V, Sharma D, Davidson BR. Techniques for liver parenchymal transection in liver resection. Cochrane Database Syst Rev 2009; (1) CD006880
  • 37 Gurusamy KS, Li J, Sharma D, Davidson BR. Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database Syst Rev 2009; (4) CD008085
  • 38 Gurusamy KS, Li J, Vaughan J, Sharma D, Davidson BR. Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database Syst Rev 2012; 5 (5) CD007338
  • 39 Strasberg SM, Belghiti J, Clavien PA , et al. The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2: 333-339
  • 40 Ishizaki Y, Yoshimoto J, Miwa K, Sugo H, Kawasaki S. Safety of prolonged intermittent pringle maneuver during hepatic resection. Arch Surg 2006; 141 (7) 649-653 , discussion 654
  • 41 Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg 1996; 224 (2) 155-161
  • 42 Simillis C, Li T, Vaughan J, Becker LA, Davidson BR, Gurusamy KS. Methods to decrease blood loss during liver resection: a network meta-analysis. Cochrane Database Syst Rev 2014; 4 (4) CD010683
  • 43 Koea JB, Batiller J, Patel B , et al. A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery. HPB (Oxford) 2013; 15 (1) 61-70
  • 44 Cauchy F, Gaujoux S, Ronot M , et al. Local venous thrombotic risk of an expanding haemostatic agent used during liver resection. World J Surg 2014; 38 (9) 2363-2369
  • 45 Rees M, Plant G, Wells J, Bygrave S. One hundred and fifty hepatic resections: evolution of technique towards bloodless surgery. Br J Surg 1996; 83 (11) 1526-1529
  • 46 Cunningham JD, Fong Y, Shriver C, Melendez J, Marx WL, Blumgart LH. One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg 1994; 129 (10) 1050-1056
  • 47 Melendez JA, Arslan V, Fischer ME , et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998; 187 (6) 620-625
  • 48 Rahbari NN, Koch M, Zimmermann JB , et al. Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg 2011; 253 (6) 1102-1110
  • 49 Uchiyama K, Ueno M, Ozawa S , et al. Half clamping of the infrahepatic inferior vena cava reduces bleeding during a hepatectomy by decreasing the central venous pressure. Langenbecks Arch Surg 2009; 394 (2) 243-247
  • 50 Luo L-X, Yu Z-Y, Bai Y-N. Laparoscopic hepatectomy for liver metastases from colorectal cancer: a meta-analysis. J Laparoendosc Adv Surg Tech A 2014; 24 (4) 213-222
  • 51 Lochan R, Ansari I, Coates R, Robinson SM, White SA. Methods of haemostasis during liver resection—a UK national survey. Dig Surg 2013; 30 (4-6) 375-382
  • 52 Bezeaud A, Denninger MH, Dondero F , et al. Hypercoagulability after partial liver resection. Thromb Haemost 2007; 98 (6) 1252-1256
  • 53 Kobayashi S, Yokoyama Y, Matsushita T , et al. Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy. Arch Surg 2012; 147 (10) 909-917
  • 54 Shontz R, Karuparthy V, Temple R, Brennan TJ. Prevalence and risk factors predisposing to coagulopathy in patients receiving epidural analgesia for hepatic surgery. Reg Anesth Pain Med 2009; 34 (4) 308-311
  • 55 Weinberg L, Scurrah N, Gunning K, McNicol L. Postoperative changes in prothrombin time following hepatic resection: implications for perioperative analgesia. Anaesth Intensive Care 2006; 34 (4) 438-443
  • 56 Siniscalchi A, Begliomini B, De Pietri L , et al. Increased prothrombin time and platelet counts in living donor right hepatectomy: implications for epidural anesthesia. Liver Transpl 2004; 10 (9) 1144-1149
  • 57 Matsukawa M, Kaikita K, Soejima K , et al. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction. Am J Cardiol 2007; 100 (5) 758-763
  • 58 De Pietri L, Montalti R, Begliomini B , et al. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability?. Eur J Anaesthesiol 2010; 27 (7) 608-616
  • 59 Tapper EB, Tanaka KA, Sarmiento JM. Evaluation of hemostatic factors in patients undergoing major hepatic resection and other major abdominal surgeries. Am Surg 2011; 77 (9) 1188-1193
  • 60 Giovannini I, Chiarla C, Giuliante F, Vellone M, Nuzzo G. Modulation of plasma fibrinogen levels in acute-phase response after hepatectomy. Clin Chem Lab Med 2004; 42 (3) 261-265
  • 61 Meijer C, Wiezer MJ, Hack CE , et al. Coagulopathy following major liver resection: the effect of rBPI21 and the role of decreased synthesis of regulating proteins by the liver. Shock 2001; 15 (4) 261-271
  • 62 Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27 (2) 81-90
  • 63 Barton JS, Riha GM, Differding JA , et al. Coagulopathy after a liver resection: is it over diagnosed and over treated?. HPB (Oxford) 2013; 15 (11) 865-871
  • 64 Pulitanò C, Aldrighetti L, Arru M , et al. Preoperative methylprednisolone administration maintains coagulation homeostasis in patients undergoing liver resection: importance of inflammatory cytokine modulation. Shock 2007; 28 (4) 401-405
  • 65 Pulitanò C, Aldrighetti L, Arru M , et al. Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resection. HPB (Oxford) 2007; 9 (3) 183-189
  • 66 Neal CP, Mann CD, Garcea G, Briggs CD, Dennison AR, Berry DP. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg 2011; 146 (4) 471-478
  • 67 Richardson AJ, Laurence JM, Lam VWT. Use of pre-operative steroids in liver resection: a systematic review and meta-analysis. HPB (Oxford) 2014; 16 (1) 12-19
  • 68 Tzeng C-WD, Katz MHG, Fleming JB , et al. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 2012; 14 (8) 506-513
  • 69 Weiss MJ, Kim Y, Ejaz A , et al. Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons. HPB (Oxford) 2014; 16 (10) 892-898
  • 70 Morris RJ, Woodcock JP. Evidence-based compression: prevention of stasis and deep vein thrombosis. Ann Surg 2004; 239 (2) 162-171
  • 71 Comerota AJ, Chouhan V, Harada RN , et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997; 226 (3) 306-313 , discussion 313–314
  • 72 Roderick P, Ferris G, Wilson K , et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess 2005; 9 (49) iii-iv , ix–x, 1–78
  • 73 Urbankova J, Quiroz R, Kucher N, Goldhaber SZ. Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients. Thromb Haemost 2005; 94 (6) 1181-1185
  • 74 Geerts WH, Bergqvist D, Pineo GF , et al; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6, Suppl): 381S-453S
  • 75 Tzeng C-WD, Curley SA, Vauthey JN, Aloia TA. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford) 2013; 15 (10) 773-780
  • 76 Leonardi MJ, Hollander LL, Pitt HA , et al. Acute Portomesenteric Venous Thrombosis Following Abdominal Surgery: Observe, Anticoagulate or Operate?. Conference proceedings for The Society for Surgery of the Alimentary Tract; 2011
  • 77 Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterol 2002; 97 (3) 535-541
  • 78 Thomas RM, Ahmad SA. Management of acute post-operative portal venous thrombosis. J Gastrointest Surg 2010; 14 (3) 570-577
  • 79 Plessier A, Darwish-Murad S, Hernandez-Guerra M , et al; European Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010; 51 (1) 210-218
  • 80 Amitrano L, Guardascione MA, Scaglione M , et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007; 102 (11) 2464-2470